Table 1 Characteristics of study population, CNNS, 2016–18. Prevalence of Insulin IR is in percentage
Characteristics | Weighted % | Mean TyG Index ± SD | Prevalence of Insulin resistance |
|---|---|---|---|
Gender** | |||
 Male | 51.40 | 4.46 ± 0.25 | 21.1 |
 Female | 48.60 | 4.49 ± 0.23 | 23.5 |
Age** | |||
 10–14 | 53.75 | 4.49 ± 0.24 | 23.3 |
 15–19 | 46.25 | 4.47 ± 0.24 | 21.1 |
Place of Residence** | |||
 Rural | 56.87 | 4.48 ± 0.24 | 21.4 |
 Urban | 43.13 | 4.47 ± 0.24 | 23.0 |
Wealth Index*** | |||
 Poorest | 8.01 | 4.48 ± 0.24 | 22.8 |
 Poor | 13.07 | 4.49 ± 0.24 | 22.4 |
 Middle | 20.00 | 4.49 ± 0.24 | 24.0 |
 Rich | 26.83 | 4.49 ± 0.24 | 23.9 |
 Richest | 32.09 | 4.46 ± 0.24 | 19.8 |
Religion*** | |||
 Hindu | 72.64 | 4.46 ± 0.24 | 20.4 |
 Muslim | 11.22 | 4.50 ± 0.24 | 24.8 |
 Christian | 10.13 | 4.54 ± 0.25 | 31.7 |
 Sikh | 2.50 | 4.43 ± 0.20 | 14.3 |
 Other | 3.52 | 4.54 ± 0.25 | 34.0 |
Caste*** | |||
 Scheduled Caste (SC) | 20.93 | 4.45 ± 0.23 | 19.7 |
 Scheduled Tribe (ST) | 19.53 | 4.51 ± 0.25 | 26.9 |
 Other Backward Class (OBC) | 35.05 | 4.45 ± 0.22 | 17.3 |
 Others | 24.49 | 4.49 ± 0.24 | 23.3 |
Zone*** | |||
 North | 21.97 | 4.45 ± 0.22 | 16.3 |
 Central | 10.17 | 4.42 ± 0.21 | 13.5 |
 East | 17.86 | 4.51 ± 0.24 | 26.6 |
 West | 10.33 | 4.42 ± 0.22 | 15.4 |
 South | 15.91 | 4.41 ± 0.23 | 14.2 |
 North-East | 23.77 | 4.58 ± 0.25 | 36.8 |
BMI1*** | |||
 Underweight | 20.49 | 4.45 ± 0.23 | 17.7 |
 Normal | 71.14 | 4.47 ± 0.24 | 21.6 |
 Overweight/obese | 8.37 | 4.58 ± 0.25 | 37.9 |
Vitamin D*** | |||
 Adequate | 38.65 | 4.43 ± 0.23 | 16.52 |
 Insufficient | 36.71 | 4.48 ± 0.24 | 23.56 |
 Deficient | 24.64 | 4.51 ± 0.24 | 26.02 |
Hypertension2** | |||
 No | 68.26 | 4.48 ± 0.24 | 22.2 |
 Yes | 31.74 | 4.49 ± 0.24 | 24.7 |
Serum Cholesterol (quantiles)*** | |||
 Q1 (113—118 mg/dl) | 25.16 | 4.38 ± 0.22 | 10.22 |
 Q2 (119—137 mg/dl) | 25.86 | 4.44 ± 0.21 | 14.71 |
 Q3 (138—158 mg/dl) | 24.47 | 4.48 ± 0.21 | 19.17 |
 Q4 (159—379 mg/dl) | 24.51 | 4.60 ± 0.25 | 38.85 |
Serum creatinine (quantiles)*** | |||
 Q1 (0.10—0.50 mg/dl) | 39.78 | 4.46 ± 0.22 | 14.52 |
 Q2 (0.60—0.60 mg/dl) | 21.05 | 4.45 ± 0.23 | 17.30 |
 Q3 (0.70—0.70 mg/dl) | 15.16 | 4.46 ± 0.23 | 17.90 |
 Q4 (0.80—4.50 mg/dl) | 24.02 | 4.54 ± 0.27 | 31.13 |
Total |  | 4.48 ± 0.24 | 22.3 |